Birmingham Children's Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK.
Royal Orthopaedic Hospital, Bristol Road South, Birmingham, B31 2AP, UK.
Syst Rev. 2024 Feb 23;13(1):72. doi: 10.1186/s13643-023-02444-6.
Developmental dysplasia of the hip (DDH) affects 1-3% of newborns and 20% of cases are bilateral. The optimal surgical management strategy for patients with bilateral DDH who fail bracing, closed reduction or present too late for these methods to be used is unclear. There are proponents of both medial approach open reduction (MAOR) and anterior approach open reduction (AOR); however, there is little evidence to inform this debate.
We will perform a systematic review designed according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol. We will search the medical and scientific databases including the grey and difficult to locate literature. The Medical Subject Headings "developmental dysplasia of the hip", "congenital dysplasia of the hip", "congenital hip dislocation", "developmental hip dislocation", and their abbreviations, "DDH" and "CDH" will be used, along with the qualifier "bilateral". Reviewers will independently screen records for inclusion and then independently extract data on study design, population characteristics, details of operative intervention and outcomes from the selected records. Data will be synthesised and a meta-analysis performed if possible. If not possible we will analyse data according to Systematic Review without Meta-Analysis guidance. All studies will be assessed for risk of bias. For each outcome measure a summary of findings will be presented in a table with the overall quality of the recommendation assessed using the Grading of Recommendations Assessment Development and Evaluation approach.
The decision to perform MAOR or AOR in patients with bilateral DDH who have failed conservative management is not well informed by the current literature. High-quality, comparative studies are exceptionally challenging to perform for this patient population and likely to be extremely uncommon. A systematic review provides the best opportunity to deliver the highest possible quality of evidence for bilateral DDH surgical management.
The protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO ID CRD42022362325).
发育性髋关节发育不良(DDH)影响 1-3%的新生儿,其中 20%为双侧病例。对于 brace 治疗、闭合复位失败或因太晚而无法采用这些方法的双侧 DDH 患者,其最佳手术治疗策略尚不明确。对于采用内侧入路切开复位(MAOR)还是前侧入路切开复位(AOR),支持者各有不同;然而,目前几乎没有证据可以支持这一争论。
我们将按照系统评价和荟萃分析首选报告项目的要求进行系统评价。我们将检索包括灰色文献和难以定位文献在内的医学和科学数据库。将使用“发育性髋关节发育不良”、“先天性髋关节发育不良”、“先天性髋关节脱位”和其缩写词“DDH”和“CDH”作为主题词,并加上“双侧”作为限定词。审查员将独立筛选纳入记录,然后独立从选定记录中提取研究设计、人群特征、手术干预细节和结果的数据。如果可能,将对数据进行综合分析并进行荟萃分析;如果不可能,我们将根据系统评价但不进行荟萃分析的指导对数据进行分析。所有研究都将评估偏倚风险。对于每个结局指标,将在一个表格中汇总发现,使用推荐评估、制定与评价分级方法评估总体推荐质量。
对于保守治疗失败的双侧 DDH 患者,选择进行 MAOR 还是 AOR 手术,目前的文献并不能提供很好的依据。对于这类患者人群,进行高质量、对照研究极具挑战性,且极可能极为罕见。系统评价为提供双侧 DDH 手术治疗的最高质量证据提供了最佳机会。
该方案已在国际前瞻性系统评价注册库(PROSPERO 登记号 CRD42022362325)中进行了注册。